Despite compulsory licensing, generic cancer drug too costly for the poor
- Nirmalya Dutta
March 21, 2012 at 09:18am
Despite the ruling earlier this week that allowed Natco, an Indian pharmacy to copy Bayer’s Nexavar, a blockbuster cancer drug that will bring …

more articles...

Ask an expert

You agree to the terms and conditions by posting your question

Post question anonymously (Your name would not be displayed on screen)


more news...